Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2005 | 04-2004 | 04-2003 | 04-2002 | 04-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85 | 120 | 195 | 449 | 452 |
| Receivables | N/A | 23 | N/A | N/A | 1 |
| Inventories | N/A | 30 | 24 | 26 | 25 |
| Other current assets | 171 | 0 | 0 | 0 | 0 |
| TOTAL | $256 | $180 | $230 | $489 | $495 |
| Non-Current Assets | |||||
| PPE Net | N/A | 201 | 246 | 286 | 320 |
| Investments And Advances | 0 | 0 | 0 | 0 | 50 |
| Other Non-Current Assets | 11 | 11 | 11 | 11 | 11 |
| TOTAL | $11 | $212 | $258 | $297 | $381 |
| Total Assets | $267 | $392 | $487 | $786 | $876 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 70 | 93 | 65 | 88 | 126 |
| TOTAL | $633 | $592 | $693 | $784 | $712 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 3 | N/A | 129 | 69 |
| TOTAL | $N/A | $N/A | $4 | $7 | $14 |
| Total Liabilities | $633 | $592 | $697 | $791 | $725 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,401 | 735 | 709 | 709 | 709 |
| Common Shares | 17 | 9 | 9 | 9 | 9 |
| Retained earnings | -6,631 | -6,384 | -6,147 | -5,937 | -5,726 |
| Other shareholders' equity | 0 | 0 | 0 | 531 | 531 |
| TOTAL | $-367 | $-200 | $-210 | $-5 | $151 |
| Total Liabilities And Equity | $267 | $392 | $487 | $786 | $876 |